Streetbeat News

Equity Actions

AER

AerCap Holdings NV (NYSE:AER) reported its Q4 FY23 activities, including signing 179 lease agreements, acquiring 20 airlines, and repurchasing 10 million shares. The company received $609 million from insurance settlements and signed financing transactions worth $1.7 billion. In 2023, AER repurchased 44 million shares for $2.6 billion and held $2.61 billion in cash and equivalents as of Sept. 30, 2023. AER also leased two Airbus A321 P2F aircraft to Swiftair last month. AER shares closed down 2.34% at $70.66.

Portfolio Pulse from Lekha Gupta

January 04, 2024 | 5:50 pm

PCLOF

Benuvia Operations LLC and PharmaCielo Ltd (OTCQX:PCLOF) (TSXV:PCLO) have announced a strategic partnership to manufacture CGMP pharmaceutical-grade Active Pharmaceutical Ingredients (APIs) for the global market. PharmaCielo will cultivate cannabis and hemp in Colombia, while Benuvia will produce the final product in Texas. The partnership aims to offer Seed-to-Pharma products globally, ensuring quality and compliance. PharmaCielo also plans to issue common shares to satisfy interest payments on debentures. PCLOF's shares were trading at $0.107 at the time of the announcement.

Portfolio Pulse from Patricio Liddle

January 04, 2024 | 5:11 pm

PM

Philip Morris Intl (NYSE:PM) has seen significant options trading activity, with a bearish sentiment from high-rolling investors. Benzinga's options scanner detected 8 trades, with 37% bullish and 62% bearish sentiment. The trades suggest a target price range of $90 to $100 over the next three months. The company, known for its tobacco products, has diversified with acquisitions of Swedish Match and Vectura. PM's stock is currently at $95.42, with potential overbought conditions and earnings expected in 35 days.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:01 pm

AVTR

Avantor (NYSE:AVTR) has been evaluated by 8 analysts over the last three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $23.94, up from the previous $22.50. Analysts from firms like Evercore ISI Group, Deutsche Bank, Barclays, TD Cowen, Goldman Sachs, Morgan Stanley, and Raymond James have updated their ratings and price targets, reflecting changes in market conditions and company performance. Avantor operates in various industries and has a lower market capitalization compared to industry averages. Its revenue growth has declined by -7.34%, but it maintains a high net margin of 6.3% and an exceptional ROE of 2.14%. However, its debt-to-equity ratio of 1.1 is higher than the industry average.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

PKG

Packaging Corp of America (NYSE:PKG) received diverse analyst ratings over the last three months, with a recent shift towards a more bullish outlook. The average 12-month price target for PKG has increased to $161.6, up 6.74% from the previous target. Analysts from Truist Securities, Wells Fargo, Citigroup, and Jefferies have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. PKG's financials show a negative revenue trend with a -8.93% decline, but strong profitability with a high net margin of 9.39% and above-average ROE and ROA. The company's debt-to-equity ratio is conservative at 0.71.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

ATXI

DYN

MBLY

OMGA

OPK

SLS

U.S. stocks saw gains with the Dow Jones rising by 200 points. Financial shares led the gains, while energy shares declined. The S&P Global US Services PMI was revised slightly higher for December. Dyne Therapeutics announced a public offering, Omega Therapeutics surged after a collaboration with Novo Nordisk, and Avenue Therapeutics rose on FDA agreement news. Conversely, SELLAS Life Sciences, Mobileye Global, and OPKO Health fell sharply due to a public offering, preliminary financial results, and a private offering of notes, respectively.

Portfolio Pulse from Avi Kapoor

January 04, 2024 | 5:00 pm

NVDA

SPY

NVIDIA Corporation (NASDAQ:NVDA) has seen its market capitalization exceed $1 trillion, driven by a surge in artificial intelligence interest. CEO Jensen Huang's wealth increased by $30.2 billion in 2023, making him the 29th richest person globally. NVDA shares gained over 200% in 2023, outperforming the SPDR S&P 500 ETF Trust (NYSE:SPY). A $1,000 investment in NVDA in 2014, when Huang revealed his company logo tattoo, would be worth $103,380.85 today, compared to $2,400.83 if invested in SPY. Similarly, a $1,000 investment in NVDA in 2017 would be worth $8,917.17 today, versus $1,827.64 in SPY.

Portfolio Pulse from Chris Katje

January 04, 2024 | 4:56 pm

NUZE

Bard Associates, Inc. has disclosed a 9% ownership stake in NuZee, Inc. as of December 31, 2023, according to a recent 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 4:36 pm

POLA

Bard Associates, Inc. has reported a 16% stake in Polar Power, Inc. as of December 31, 2023, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 4:32 pm

AAPL

FXI

Apple's suppliers, including Foxconn, have invested $16 billion since 2018 to diversify manufacturing away from China due to US/China trade tensions, COVID measures, and power supply issues. TD Cowen's research indicates Apple's revenues were impacted by over $30 billion during the pandemic. Reshoring efforts are aimed at reducing future production disruptions, with investments in India, Mexico, the US, and Vietnam. Apple's operating margins may benefit long-term, despite higher near-term costs. iPhone production remains largely in China, but India is emerging as a significant manufacturing hub. Vietnam is becoming a major hub for Mac and iPad production, potentially meeting 40% of US demand. The reshoring process is expected to take years, with challenges in establishing new plants and organizing supply chains.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 4:19 pm